CLINICAL STUDY AGREEMENTClinical Study Agreement • November 18th, 2021
Contract Type FiledNovember 18th, 2021The Study shall be conducted in full compliance with the Sponsor's protocol VTX002-201 “A Phase 2, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group Study to Evaluate the Clinical Efficacy and Safety of VTX002 in Subjects with Moderately to Severely Active Ulcerative Colitis” and any amendments thereto (the “Protocol”).